Reports suggest that BA inhibited gastric cancer cell migration and invasion by impairing epithelial‐mesenchymal transition signaling [56, 65] and targeting the NF-κB/VASP signaling pathway [56, 65]. This evidence concerns the gene NFKB1 and gastric cancer.